Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 163Carcinoma, Renal Cell 45Urinary Bladder Neoplasms 33Carcinoma, Transitional Cell 19Lung Neoplasms 14Melanoma 11Neoplasm Metastasis 10Glioma 10Breast Neoplasms 9Wilms Tumor 8Ovarian Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Sarcoma 7Kidney Neoplasms 7Colorectal Neoplasms 7Uterine Cervical Neoplasms 6Ureteral Neoplasms 6Testicular Neoplasms 6Rhabdoid Tumor 6Pancreatic Neoplasms 6Neuroectodermal Tumors, Primitive, Peripheral 6Neuroblastoma 6Medulloblastoma 6Lymphoma, Non-Hodgkin 6Histiocytosis, Langerhans-Cell 6Hepatoblastoma 6Ependymoma 6Clear-cell metastatic renal cell carcinoma 6Carcinoma, Hepatocellular 6Brain Neoplasms 6

Interventions

Multiparametric Magnetic Resonance Imaging 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Genetic Testing 1Exome 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Predisposition to Disease × Magnetic Resonance Spectroscopy × Genitourinary × Clear all
NCT06636526 2026-02-04

The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).

Institute of Cancer Research, United Kingdom

Recruiting
1,000 enrolled
Genitourinary

Genetic Risk Score, Prostatic Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡